Abstract:Introduction and Objectives Acute-on-chronic liver failure (ACLF) is an abrupt worsening of clinical conditions in patients with chronic liver disease. It has a higher mortality rate with respect to patients who do not develop this entity (33.9% vs. 4.7%). The lactate/albumin ratio is a statistically significant predictor (p<0.001) of mortality during hospitalization in these patients. This study aimed to determine whether the lactate-albumin ratio predicts mortality in patients with ACLF in Mexican population, identify the sociodemographic characteristics of this group of patients and to determine the related mortality at 7, 28, 90 and 180 days. Materials and Patients An observational, retrospective, single-center study was conducted where patients with diagnosis of ACLF according to the EASL-CLIF criteria who were hospitalized during the period from 2017 to 2022 in the Gastroenterology department at National Medical Centre "Siglo XXI" were included. Patients diagnosed with terminal chronic extrahepatic diseases, hepatocellular carcinoma and extrahepatic neoplasms were excluded. Results A total of 186 patients were enrolled, 51% were women, with an age range of 56-65 years, 29% were secondary to fatty liver disease associated with metabolic dysfunction, obtaining that the most frequent precipitant was the infectious origin in 111 patients (60%), with abdominal origin being the most prevalent (36%). Renal failure was present in 71%, followed by coagulopathy (50%) and neurological failure (49%). On admission, grade I ACLF was present in 37 patients (20%), grade II in 72 (39%), grade III in 77 (49%). At 7, 28, 28, 90 and 180 days 73 patients (39.5%), 146 patients (78.9%), 159 (85.9%) and 172 patients (93%) died respectively, with a lactate albumin ratio for each of these, with a cut-off point 1.24 (AUC 70.70%), 0.87(AUC 71.20%), 0.84 (AUC 73.5%) and 1.04(AUC 64.90%) respectively with statistically significant values p <0.05. Conclusions Lactate levels and its clearance have been shown to predict outcome of critically ill patients with liver cirrhosis, improving the prediction of mortality. The lactate albumin ratio is useful for predicting mortality in this group of patients at 7, 28, 90 and 180 days with adequate sensitivity and specificity. The values obtained were statistically significant as shown in the complementary tables.

LILLE-4 vs. LILLE-7 to predict short-term mortality in patients with severe alcoholic hepatitis

P- 32 VALIDATION OF LILLE-4 VERSUS LILLE-7 TO PREDICT SHORT-TERM MORTALITY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY

Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis

Comparison of prognostic scores for alcoholic hepatitis: a retrospective study

Survival of Patients with Alcohol-Related Liver Disease Cirrhosis—Usefulness of the New Liver Mortality Inpatients Prognostic Score

Prognostic Models for Acute Liver Failure.

Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trials.

Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design

Establishing a Metabolomic Model for the Prognosis of Hepatitis B Virus-Induced Acute-on-chronic Liver Failure Treated with Different Liver Support Systems

Age added to MELD or ACLF predicts survival in patients with alcohol-associated hepatitis declined for liver transplantation

Establishment of Prognostic Scoring Models for Different Etiologies of Acute Decompensation in Hospitalized Patients with Cirrhosis

T1864 Early Mortality of Alcoholic Hepatitis: A Review of Data from Placebo-Controlled Clinical Trials

Lactate-albumin ratio as a predictor of mortality in patients with acute on chronic liver failure in a third-level care hospital in Mexico

Early Mortality Of Alcoholic Hepatitis: A Review Of Data From Placebo-Controlled Clinical Trials

A Prognostic Model for Hepatitis B Acute-on-chronic Liver Failure Patients Treated Using a Plasma Exchange-Centered Liver Support System.

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

Prognostic Utility of Novel Biomarkers in Acute-on-chronic Liver Failure (ACLF) Associated with Hepatitis B: A Multicenter Prospective Study.